by transparencyrx | May 12, 2025 | Uncategorized
With today’s Executive Order, President Trump is right to focus attention on U.S. drug prices but in reality, prescription costs won’t meaningfully change unless we confront the real powerbrokers: offshore global middlemen and PBMs owned by insurance giants. The...
by transparencyrx | May 7, 2025 | Uncategorized
Transparency-Rx, a trusted, not-for-profit coalition dedicated to changing drug pricing for the better, is excited to announce its newest member, EmpiRx Health. They join a growing list of transparent pharmacy benefit management companies, leading industry experts,...
by transparencyrx | Sep 20, 2024 | Uncategorized
Transparency-Rx applauds the Federal Trade Commission today for bringing federal anti-trust action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations...
by transparencyrx | Mar 20, 2024 | News
Leaders from three leading non-profit business associations issued a united statement on Congress’ failure to include pharmacy benefit manager (PBM) reform legislation in the government spending package this week, despite clear, enormous bipartisan support to do so. ...
by transparencyrx | Feb 7, 2024 | News
Transparency-Rx, a not-for-profit coalition led by transparent pharmacy benefit managers (PBMs), today released the below statement following the House Oversight Committee’s markup of H.R. 6283 and inclusion of the Delinking Revenue from Unfair Gouging Act (DRUG Act):...
